Registration for the British Society For Microbial Technology’s 41st Annual Microbiology Conference is open now. The event takes place on Thursday 21 May, at North London’s RAF Museum, Hendon.
Features
Detection to direction: the future of precision oncology diagnostics
Advances in molecular and genomic technologies are transforming oncology diagnostics, bridging screening, risk stratification, and treatment selection into a connected model of early cancer detection.
Hyperviscosity syndrome: a complication hiding in plain sight?
David Manuel, David Norcliffe and Bernie Benson present a study of hyperviscosity syndrome, looking at its associated primary causes, along with the effects, symptoms and laboratory testing of this critical medical condition.
Products
ProtonDx's Dragonfly evaluated for identifying hidden malaria cases
A new study has shown that Dragonfly, a low-cost, rapid, molecular testing platform is successfully able to detect asymptomatic malaria infections.
New blood-based assay for Alzheimer's disease research
Precision proteomics firm Alamar Biosciences has announced the launch of the NULISAqpcr BD-pTau217 Assay, which it says is a transformative leap in blood-based quantification of brain-derived phosphorylated tau 217 (pTau217)—a pivotal biomarker in Alzheimer's disease research and other tauopathies.
Ten-colour PCR platform bridges gap between PCR and NGS
Countable Labs has announced the launch of Countable 10, the first and only PCR platform capable of 10-color multiplexing. The new platform will extend the utility of the company’s core Countable PCR technology to enable higher level multiplexing that easily and cleanly reveals more insights in a single reaction.
Gestalt launches PathFlow update
Gestalt has announced the release of PathFlow Version 6, the latest evolution of its award-winning digital pathology platform.
Latest Issues
UK NEQAS IMPROVES PATIENT CARE
We aim to improve patient care through monitoring the quality of tests and their reporting, in an independent manner and on a not-for-profit basis.
We are here to help ensure optimal quality in testing for the benefit of patients.
We believe that the result of tests should be:
UK NEQAS webinar: Specialist Demonstration of Amyloid, Fibrin and Carbohydrates
Online
10-11 February, 2026
BIVDA Regulatory Affairs Seminar
Grand Hotel, Birmingham
10 - 11 February, 2026
BDIAP Molecular Pathology Study Day
10 Union Street, London, SE1 1SZ
2 March, 2026
UK NEQAS webinar: Introduction to Cellular Components, Tissue Morphology and Tissue Recognition
Online
3-4 March, 2026
Cell & Gene Therapy 2026
Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-11 March, 2025